BioNTech
Empresa de biotecnología
BioNTech SE es una empresa de biotecnología alemana dedicada al desarrollo y fabricación de inmunoterapias activas para un enfoque específico del paciente en el tratamiento de enfermedades graves. Wikipedia
Fundadores: Uğur Şahin, Özlem Türeci y Christoph Huber
Director ejecutivo: Uğur Şahin (2008–)
Filiales: InstaDeep Ltd, BioNTech US Inc., Aexerna Therapeutics y más
Fundación: 2008
Oficinas centrales: Alemania
Fuente: S&P Capital IQ
We strive to exploit the full potential of the body's immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets ...
Más preguntas
Did Pfizer buy BioNTech?
What does BioNTech do?
Who is the parent company of BioNTech?
Where is BioNTech located in the US?
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the ...
Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, ...
Our aim is to provide therapeutic benefits for cancer patients along the entire treatment journey. https://investors.biontech.de/news-releases/news-release- ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to ...
BioNTech SE | 236128 followers on LinkedIn. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age.